---

Home Office

Answer

Dr. Tonge: To ask the Secretary of State for the Home Department if he will list the research and development projects being carried out to investigate the possible medicinal uses of (a) cannabis, (b) coca and (c) opium. [4667] Mr. Bob Ainsworth: There are 25 licences currently valid for cannabis research. The licence holders and the purposes are: _________________________________________________________________________________________________. Licence holders Purpose Prof. A. D. Smith (Univ. of Oxford) Academic Dr. R. Middleton (Univ. of Hull) Academic Dr. C. Hunter (Univ. of the West of England) Academic Dr. M. A. Sackville (Univ. of Sunderland) Academic Dr. C. Wright (Univ. of Bradford) Academic Dr. P. M. Dewick (Univ. of Nottingham) Academic Dr. J. Smart (Univ. of Portsmouth) Academic Dr. Geoffrey Hall (De Montfort Univ) Academic Prof. P. J. Houghton (Kings College London) Academic Dr. Alexander (Univ. of Edinburgh) Academic Dr. J. Cole (Royal Liverpool Univ. Hospital) Academic Prof. J. F. Alder (Univ. of Manchester Institute Academic Mr. Malcolm Aiken (Univ. of Brighton) Academic Dr. K. Brain (Welsh Sch. of Pharmacy) Academic Prof. Redfern (Univ. of Bath) Academic Prof. J. Kelly (Univ. of Edinburgh) Academic Prof. T. Stone (Univ. of Glasgow) Academic Dr. D. Todd (James Paget Hospital) Researching general therapeutic benefits Dr. D. Baker (Univ. College London) Immune systems (inc. Multiple Sclerosis (MS) research) Dr. R. Pertwee (Univ. of Aberdeen) Neuropharmacology research Dr. C. Heard (Welsh Sch. of Pharmacy) Research into transdermal administration Dr. E. Williamson (Univ. of London) Research into Multiple Sclerosis (MS) Prof. R. Rainsford (Sheffield Hallam Univ.) Research into arthritis G. W. Pharmaceuticals (Porton Down) Research into Multiple Sclerosis (MS) and other conditions Dr. J. Zajicek (Derriford Hospital) Research into Multiple Sclerosis (MS) _________________________________________________________________________________________________. None covers coca and opium.

Secondary information

Type

Written question

Reference

4667; 372 c284W

Session

2001-02

Subjects

Cannabis Licensing Drugs Medical treatments Research Opium Clinical trials Coca

Link

View this Written question on www.publications.parliament.uk